CINGULATE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6611 USD | -4.59% |
|
-8.54% | -91.36% |
| 21/05 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
| 08/05 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
62c7fe19a2d9d428c9a6688872d0607.XnddRc-aWf5W1VUan-M2G412QWsuzTctmCYvHX10L_k.Ji40M4fMMagDvGBx9awFT7VDFQ5xnk1I6XFrKBoNXrUdHCsKlu8ulh_sPg~41f433913303c02801c6a9d007d7523f
